Jiangsu Lintex Advanced Materials
920106
Beijing Chieftain Control Technology Group
300430
Jiangsu Apon Medical Technology
300753
Fujian Zitian Media Technology
300280
SigmaStar Technology
301536
CN Stock MarketDetailed Quotes
600488 Tianjin Tianyao Pharmaceuticals
- 4.53
- +0.03+0.67%
Market Closed Dec 18 15:00 CST
4.95BMarket Cap32.59P/E (TTM)
4.57High4.47Low79.99KlotVolume4.51Open4.50Pre Close36.18MTurnover0.73%Turnover Ratio42.34P/E (Static)1.09BShares5.0052wk High1.62P/B4.95BFloat Cap3.0152wk Low4.95Limit Up1.09BShs Float12.99Historical High4.05Limit Down2.22%Amplitude0.98Historical Low0.09Dividend TTM4.52Avg Price33.49KlotAsk1.92%Div YieldTTM100Lot Size45.35KlotBid
Tianjin Tianyao Pharmaceuticals Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | 79.75%818.43M | 32.02%728.32M | 7.49%720.98M | 10.98%718.86M | -17.27%455.31M | 73.87%551.68M | 145.13%670.74M | 178.94%647.74M | 138.95%550.39M | 57.79%317.3M |
| Transactional financial assets | ---- | ---- | ---- | ---- | ---- | ---- | --128.8K | ---- | ---- | ---- |
| Notes receivable and accounts receivable | -24.07%335.36M | -11.93%441.48M | 6.26%410.41M | 25.23%429.95M | 7.86%441.7M | -1.59%501.3M | -30.56%386.24M | -31.74%343.33M | -28.75%409.49M | -2.68%509.41M |
| -Notes receivable | ---- | ---- | -99.70%50K | ---- | -65.14%300K | 1,153.56%16.68M | 1,116.30%16.62M | -38.05%1.19M | -55.41%860.6K | -54.19%1.33M |
| -Accounts receivable | -24.02%335.36M | -8.90%441.48M | 11.02%410.36M | 25.67%429.95M | 8.02%441.4M | -4.62%484.62M | -33.39%369.62M | -31.72%342.14M | -28.66%408.63M | -2.39%508.08M |
| Other receivables (including interest and dividends) | -16.63%28.48M | -14.64%33.5M | 2.94%32.89M | 23.92%29.42M | 28.58%34.16M | 33.21%39.25M | 7.18%31.95M | -12.21%23.74M | 0.45%26.57M | 7.88%29.46M |
| -Dividend receivable | ---- | --0 | ---- | ---- | ---- | --0 | ---- | --0 | ---- | --0 |
| -Accrued interest receivable | ---- | --0 | ---- | ---- | ---- | --0 | ---- | --0 | ---- | --0 |
| -Other receivable | ---- | -14.64%33.5M | ---- | ---- | ---- | 33.21%39.25M | ---- | -12.21%23.74M | ---- | 23.07%29.46M |
| Advance payment | -21.97%33.58M | -1.18%30.13M | 22.30%35.13M | 217.55%48.94M | 148.17%43.03M | 42.67%30.49M | -35.92%28.72M | -63.32%15.41M | -53.44%17.34M | -45.16%21.37M |
| Inventories | -20.08%749.03M | -21.03%795.59M | -33.23%737.43M | -37.32%725.58M | -4.41%937.18M | 7.04%1.01B | 19.34%1.1B | 18.64%1.16B | -2.89%980.46M | -12.36%941.19M |
| Receivable financing | -4.27%149.79M | -18.35%137.75M | 17.27%181.99M | -4.17%148.38M | 52.03%156.48M | 38.56%168.7M | 86.08%155.19M | 65.82%154.84M | 74.19%102.92M | 80.02%121.75M |
| Other current assets | 117.65%1.55M | 98.40%4.55M | 97.31%6.08M | -61.21%6.94M | -88.60%713.54K | -54.44%2.3M | -64.45%3.08M | 92.91%17.9M | -24.41%6.26M | -5.90%5.04M |
| Total current assets | 2.30%2.12B | -5.64%2.17B | -10.74%2.12B | -10.69%2.11B | -1.19%2.07B | 18.28%2.3B | 23.85%2.38B | 25.39%2.36B | 7.59%2.09B | 0.40%1.95B |
| Non Current assets | ||||||||||
| Other equity investment | -50.34%145.49M | -50.26%144.82M | -50.16%142.83M | -50.25%141.88M | -15.45%292.99M | -7.76%291.14M | -15.03%286.59M | -15.03%285.18M | 6.94%346.53M | -16.55%315.65M |
| Long-term equity investment | 5.35%22.68M | 11.32%23.53M | 26.80%23.1M | 1.60%22.32M | -24.88%21.53M | -24.99%21.14M | -32.65%18.22M | -12.18%21.97M | 12.41%28.66M | 12.84%28.18M |
| Fixed assets | ---- | -4.64%2.92B | ---- | ---- | ---- | -2.01%3.06B | ---- | 8.70%3.05B | ---- | 17.30%3.12B |
| Fixed assets liquidation | ---- | --0 | ---- | ---- | ---- | --0 | ---- | --0 | ---- | --0 |
| Constru in process | ---- | -8.96%30.37M | ---- | ---- | ---- | -81.45%33.36M | ---- | -76.71%118.41M | ---- | -63.25%179.85M |
| Construction materials | ---- | -8.85%5M | ---- | ---- | ---- | -66.09%5.48M | ---- | -76.92%8.3M | ---- | -88.58%16.17M |
| Intangible assets | 18.63%331.48M | 13.48%311.99M | 22.13%306.51M | 19.27%303.66M | 23.05%279.43M | 18.08%274.92M | 19.98%250.98M | 32.34%254.61M | 25.94%227.09M | 77.40%232.84M |
| Development expenditure | 5.26%173.83M | 1.41%172.59M | -6.24%165.32M | -2.81%168.41M | -0.62%165.14M | 7.86%170.19M | 19.00%176.33M | 15.86%173.29M | 22.21%166.17M | 5.24%157.79M |
| Goodwill | ---- | ---- | ---- | ---- | --0 | --0 | --0 | ---- | --0 | --0 |
| Long deferred expense | ---- | ---- | ---- | ---- | --0 | --0 | 28.97%1.77M | 29.46%1.82M | 3.00%1.58M | -30.64%1.15M |
| Deferred tax assets | -11.34%36.44M | -8.83%38.31M | -4.36%37.56M | 3.53%41.81M | 48.48%41.11M | 29.18%42.02M | 20.12%39.28M | 25.82%40.38M | -34.02%27.68M | -21.40%32.53M |
| Usufruct assets | --0 | -78.39%42.29K | -79.26%84.57K | -74.99%126.86K | -50.35%169.14K | -52.14%195.65K | -14.63%407.81K | -6.94%507.24K | 469.65%340.66K | 256.94%408.79K |
| Other non current assets | -19.39%254.98M | -9.28%289.43M | -9.89%293.37M | -15.22%287.15M | -12.50%316.3M | -8.64%319.05M | -12.56%325.58M | -10.47%338.69M | -5.07%361.49M | -10.34%349.23M |
| Total non current assets | -7.72%3.87B | -6.72%3.93B | -5.75%4B | -5.96%4.03B | -4.17%4.2B | -4.94%4.22B | -5.09%4.24B | -3.86%4.29B | -0.45%4.38B | 0.59%4.43B |
| Total assets | -4.41%5.99B | -6.34%6.1B | -7.55%6.12B | -7.64%6.14B | -3.21%6.27B | 2.14%6.52B | 3.61%6.62B | 4.82%6.65B | 2.02%6.47B | 0.53%6.38B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | -65.54%93.08M | -81.79%81.74M | -58.99%221.19M | -58.32%270.25M | -58.34%270.11M | -24.46%448.73M | -14.32%539.37M | 10.14%648.34M | 12.12%648.31M | 2.87%594.05M |
| Notes payable and accounts payable | 4.22%722.21M | 12.45%850.22M | -14.57%685.14M | -9.25%719.55M | 13.60%692.96M | 26.03%756.11M | 50.71%801.95M | 40.10%792.9M | -6.18%610.01M | -0.17%599.93M |
| -Notes payable | 200.34%126.14M | 513.23%141.66M | -60.92%72.92M | -76.74%38.56M | -17.65%42M | -75.68%23.1M | 159.14%186.58M | 171.77%165.78M | -22.73%51M | 39.71%95M |
| -Accounts payable | -8.43%596.07M | -3.34%708.56M | -0.51%612.22M | 8.59%680.99M | 16.45%650.96M | 45.17%733.01M | 33.75%615.37M | 24.20%627.12M | -4.31%559.01M | -5.26%504.93M |
| Contract liabilities | 5.22%87.18M | -15.65%90.2M | 32.58%142.23M | 2.29%137.19M | 89.57%82.85M | 146.77%106.94M | 107.50%107.27M | 96.21%134.11M | 209.92%43.7M | 169.23%43.34M |
| Advance receipts | -69.55%148.74K | -12.05%477.82K | 30.18%741.34K | -65.78%475.9K | -95.28%488.54K | -94.61%543.27K | -80.33%569.48K | -92.27%1.39M | -34.01%10.34M | -22.78%10.07M |
| Salaries payable | 24.51%94.48M | 30.17%79.33M | 41.07%61.07M | 143.60%99.08M | 47.47%75.88M | 26.99%60.94M | 34.80%43.29M | 67.71%40.67M | 57.03%51.46M | 59.62%47.99M |
| Taxs payable | -37.55%28.74M | -29.56%33.53M | -14.58%31.65M | 45.62%42.83M | 48.60%46.02M | 55.41%47.6M | -8.41%37.06M | -26.81%29.41M | 13.99%30.97M | -25.90%30.63M |
| Other payable (including interest and dividends) | -14.52%249.93M | -5.59%267.04M | -19.83%265.43M | -22.13%249.82M | -1.62%292.39M | 2.25%282.85M | 14.49%331.07M | 22.17%320.81M | 3.35%297.21M | -3.80%276.62M |
| -Interest payable | ---- | ---- | ---- | ---- | --70.76K | --0 | ---- | --0 | ---- | ---- |
| -Dividend payable | -99.76%47.37K | 200.30%283.56K | -17.66%105.56K | 2.79%134.74K | 36.16%19.62M | -23.93%94.43K | -64.82%128.21K | -64.03%131.09K | -18.10%14.41M | -98.78%124.13K |
| -Other payable | ---- | -5.66%266.76M | ---- | ---- | --272.7M | 2.27%282.76M | ---- | 22.29%320.68M | ---- | 0.15%276.49M |
| Non current liabilities due within one year | -63.02%149.7M | 27.59%306.74M | 36.15%404.65M | 36.63%404.7M | 36.27%404.8M | -46.77%240.41M | -34.36%297.22M | -34.37%296.21M | -33.69%297.07M | 83.23%451.67M |
| Other current liabilities | -22.31%8.24M | -21.99%9.97M | 41.79%17.3M | 0.91%16.4M | -30.08%10.61M | 212.62%12.79M | 125.66%12.2M | 282.90%16.25M | 762.91%15.17M | 119.99%4.09M |
| Total current liabilities | -23.58%1.43B | -12.15%1.72B | -15.70%1.83B | -14.90%1.94B | -6.39%1.88B | -4.93%1.96B | 6.57%2.17B | 12.68%2.28B | -2.49%2B | 13.42%2.06B |
| Current liabilities | ||||||||||
| Long term loan | 90.20%529.7M | -19.42%373.47M | -32.53%296.5M | -39.60%277M | -39.28%278.5M | 51.64%463.48M | 25.70%439.48M | 24.89%458.64M | 33.16%458.64M | -43.26%305.64M |
| Long term salaries pay | --8.06M | --8.06M | --8.06M | --8.06M | ---- | ---- | ---- | --0 | ---- | ---- |
| Deferred tax liabilities | -55.14%17.79M | -54.68%17.96M | -54.29%17.94M | -53.90%18.12M | -19.77%39.65M | -11.60%39.63M | -17.41%39.25M | -17.32%39.3M | 7.89%49.41M | -16.93%44.83M |
| Long term deferred income | -6.26%142.83M | -2.99%144.88M | 10.73%142.26M | 23.19%144.99M | 32.40%152.36M | 27.61%149.34M | 9.59%128.47M | 31.41%117.7M | 29.24%115.08M | 28.91%117.03M |
| Lease liabilities | ---- | ---- | ---- | ---- | -80.93%14.33K | -71.59%39.99K | -73.36%74.17K | -57.98%115.1K | 16.42%75.14K | 16.42%140.78K |
| Other non current liabilities | -25.00%713.37K | -29.25%713.37K | -29.25%713.37K | -29.25%713.37K | -24.53%951.15K | --1.01M | --1.01M | --1.01M | --1.26M | ---- |
| Total non current liabilities | 48.28%699.09M | -16.59%545.08M | -23.48%465.47M | -27.22%448.88M | -24.50%471.48M | 39.74%653.5M | 18.19%608.28M | 22.23%616.76M | 30.28%624.47M | -31.59%467.65M |
| Total liabilities | -9.15%2.13B | -13.26%2.26B | -17.40%2.29B | -17.53%2.39B | -10.69%2.35B | 3.34%2.61B | 8.91%2.78B | 14.58%2.9B | 3.70%2.63B | 1.10%2.53B |
| Shareholders equity | ||||||||||
| Paid-in capital | -0.19%1.09B | 0.00%1.09B | -0.21%1.09B | -0.22%1.09B | -0.22%1.09B | -0.22%1.09B | -0.35%1.1B | -0.33%1.1B | -0.36%1.1B | -0.40%1.1B |
| Capital reserve funds | -1.12%320.38M | -0.45%322.19M | -1.45%322.19M | -1.50%322.19M | -2.25%324M | -2.24%323.66M | -2.62%326.95M | -2.36%327.1M | -1.14%331.46M | -2.22%331.07M |
| Surplus reserve funds | -1.45%237.48M | 5.05%248.42M | 4.10%242.98M | 3.60%237.48M | 11.41%240.99M | 9.32%236.46M | 7.90%233.4M | 5.98%229.24M | 0.00%216.31M | 0.00%216.31M |
| Retained profit | 4.67%1.35B | 2.26%1.29B | 7.12%1.31B | 8.44%1.26B | 8.45%1.29B | 5.59%1.27B | 4.08%1.22B | 0.62%1.16B | 2.73%1.19B | 4.14%1.2B |
| Less:Treasury stock | --0 | 0.00%4.73M | -53.03%4.73M | -54.29%4.73M | -54.29%4.73M | -54.29%4.73M | -46.62%10.06M | -45.15%10.34M | -47.09%10.34M | -49.71%10.34M |
| Other composite income | -71.73%49.7M | -71.53%49.66M | -71.69%47.84M | -72.10%46.95M | -20.01%175.82M | -9.09%174.45M | -19.12%169M | -18.99%168.27M | 10.31%219.82M | -21.77%191.88M |
| Specific reserves | -22.44%2.15M | -69.79%1.2M | -85.30%569.04K | --0 | 13.57%2.78M | 244.22%3.97M | 559.14%3.87M | 1,262.14%2.08M | 77.81%2.44M | 63.27%1.15M |
| Shareholders equity without minority interests | -2.28%3.05B | -2.86%3B | -0.97%3.01B | -0.64%2.95B | 2.54%3.12B | 2.26%3.09B | 0.81%3.04B | -0.69%2.97B | 1.83%3.04B | -0.23%3.02B |
| Minority interests | 1.20%805.93M | 2.64%834.69M | 1.66%813.78M | 2.36%799.75M | -0.45%796.35M | -1.95%813.25M | -2.56%800.48M | -5.16%781.33M | -2.49%799.95M | 1.62%829.38M |
| Total shareholder equity | -1.57%3.86B | -1.72%3.84B | -0.42%3.83B | -0.01%3.75B | 1.91%3.92B | 1.35%3.91B | 0.09%3.84B | -1.65%3.75B | 0.90%3.84B | 0.16%3.85B |
| Total liabilityies and equity | -4.41%5.99B | -6.34%6.1B | -7.55%6.12B | -7.64%6.14B | -3.21%6.27B | 2.14%6.52B | 3.61%6.62B | 4.82%6.65B | 2.02%6.47B | 0.53%6.38B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | China Audit China Certified Public Accountants Firm (Special General Partnership) | -- | -- | -- | China Audit China Certified Public Accountants Firm (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.